HEADLINES

In a new study led by Jatinder Lamba, Ph.D., a multi-gene metric known as ACS10 revealed a close link between genetic factors and racial disparities in pediatric acute myeloid leukemia outcomes. Researchers say using the metric to optimize treatment approaches for each patient could potentially lead to better outcomes, particularly among Black children.

Writing in the journal Nature Chemical Biology, a team led by chemist Ben Shen, Ph.D., described discovery of two new enzymes, ones with uniquely useful properties that could help in the fight against human diseases including cancer. The discovery, published last week, offers potentially easier ways to study and manufacture complex natural chemicals, including those that could become medicines.

Sherise Rogers, M.D., received the inaugural Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award from Conquer Cancer, the American Society of Clinical Oncology Foundation, funded by the Bristol Myers Squibb Foundation.

Pastor Gerard Duncan, an outreach adviser for the UF Health Cancer Center, was honored with a University of Florida Win Phillips Town Gown Relations Award in recognition of his work advocating for health care in underserved neighborhoods.

Several members of the UF Health Cancer Center’s Cancer Control and Population Sciences research program will have new space in the multidisciplinary space, which will serve as a hub for advancing computing, communication and cyber technologies and further support UF’s work to integrate AI across the curriculum.

UF Health researchers have deployed AI to refine and accelerate the evaluation of a common type of brain tumor.

The symposium provided the opportunity to learn more about cancer research that supports individuals through their cancer journey. 

Continuing their support in the fight against pediatric cancer, Stop Children’s Cancer Inc. has renewed a $1 million gift to the UF College of Medicine division of pediatric hematology/oncology. This contribution will fuel research innovations in therapies and treatments aimed at improving outcomes for children facing cancer.

Elias Sayour, M.D., Ph.D., a UF Health physician-scientist and principal investigator with the Preston A. Wells, Jr. Center for Brain Tumor Therapy, shared updates on the UF Pediatric Cancer Immunotherapy Initiative, including his innovative research using RNA nanoparticle vaccines.

This revolutionary system brings many advantages, including enhanced throughput, reduced run times and uncompromised sequencing data quality.

A new study of 99 patients with primary brain tumors offers insight into factors that may predict symptom trajectories of anxiety and depression. The study was co-led by UF Health Cancer Center members Ashley P. Ghiaseddin, M.D., and Deidre B. Pereira, Ph.D.

A new study of 99 patients with primary brain tumors offers insight into factors that may predict symptom trajectories of anxiety and depression. The study was co-led by UF Health Cancer Center members Ashley P. Ghiaseddin, M.D., and Deidre B. Pereira, Ph.D.